Fixed-Dose Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: Results of a Randomized, Placebo-Controlled Study and Open-Label Extension - Bull, J; Wellman, C V; Israel, R J (J Palliat Med, 2015)
et al.